Literature DB >> 25166047

Bone disease in primary hyperparathyroidism.

Francisco Bandeira1, Natalie E Cusano2, Barbara C Silva3, Sara Cassibba4, Clarissa Beatriz Almeida1, Vanessa Caroline Costa Machado1, John P Bilezikian2.   

Abstract

Bone disease in severe primary hyperparathyroidism (PHPT) is described classically as osteitis fibrosa cystica (OFC). Bone pain, skeletal deformities and pathological fractures are features of OFC. Bone mineral density is usually extremely low in OFC, but it is reversible after surgical cure. The signs and symptoms of severe bone disease include bone pain, pathologic fractures, proximal muscle weakness with hyperreflexia. Bone involvement is typically characterized as salt-and-pepper appearance in the skull, bone erosions and bone resorption of the phalanges, brown tumors and cysts. In the radiography, diffuse demineralization is observed, along with pathological fractures, particularly in the long bones of the extremities. In severe, symptomatic PHPT, marked elevation of the serum calcium and PTH concentrations are seen and renal involvement is manifested by nephrolithiasis and nephrocalcinosis. A new technology, recently approved for clinical use in the United States and Europe, is likely to become more widely available because it is an adaptation of the lumbar spine DXA image. Trabecular bone score (TBS) is a gray-level textural analysis that provides an indirect index of trabecular microarchitecture. Newer technologies, such as high-resolution peripheral quantitative computed tomography (HR-pQCT), have provided further understanding of the microstructural skeletal features in PHPT.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25166047      PMCID: PMC4315357          DOI: 10.1590/0004-2730000003381

Source DB:  PubMed          Journal:  Arq Bras Endocrinol Metabol        ISSN: 0004-2730


  54 in total

1.  Bone microarchitecture assessed by TBS predicts osteoporotic fractures independent of bone density: the Manitoba study.

Authors:  Didier Hans; Andrew L Goertzen; Marc-Antoine Krieg; William D Leslie
Journal:  J Bone Miner Res       Date:  2011-11       Impact factor: 6.741

2.  Analysis of the diagnostic presentation profile, parathyroidectomy indication and bone mineral density follow-up of Brazilian patients with primary hyperparathyroidism.

Authors:  U E M Oliveira; M N Ohe; R O Santos; O Cervantes; M Abrahão; M Lazaretti-Castro; J G H Vieira; O M Hauache
Journal:  Braz J Med Biol Res       Date:  2007-04       Impact factor: 2.590

3.  A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery.

Authors:  S J Silverberg; E Shane; T P Jacobs; E Siris; J P Bilezikian
Journal:  N Engl J Med       Date:  1999-10-21       Impact factor: 91.245

4.  Investigation of insulin resistance in patients with normocalcemic primary hyperparathyroidism.

Authors:  Ilkay Cakir; Kursad Unluhizarci; Fatih Tanriverdi; Gulsah Elbuken; Zuleyha Karaca; Fahrettin Kelestimur
Journal:  Endocrine       Date:  2012-02-12       Impact factor: 3.633

5.  Consequences of long-term hyperparathyroidism.

Authors:  M B Graal; B H Wolffenbuttel
Journal:  Neth J Med       Date:  1998-07       Impact factor: 1.422

6.  Trabecular bone score (TBS)--a novel method to evaluate bone microarchitectural texture in patients with primary hyperparathyroidism.

Authors:  Barbara Campolina Silva; Stephanie Boutroy; Chiyuan Zhang; Donald Jay McMahon; Bin Zhou; Ji Wang; Julia Udesky; Serge Cremers; Marta Sarquis; Xiang-Dong Edward Guo; Didier Hans; John Paul Bilezikian
Journal:  J Clin Endocrinol Metab       Date:  2013-03-22       Impact factor: 5.958

Review 7.  Hungry bone syndrome: still a challenge in the post-operative management of primary hyperparathyroidism: a systematic review of the literature.

Authors:  J E Witteveen; S van Thiel; J A Romijn; N A T Hamdy
Journal:  Eur J Endocrinol       Date:  2013-02-20       Impact factor: 6.664

8.  Medical observation, compared with parathyroidectomy, for asymptomatic primary hyperparathyroidism: a prospective, randomized trial.

Authors:  Jens Bollerslev; Svante Jansson; Charlotte L Mollerup; Jörgen Nordenström; Eva Lundgren; Ove Tørring; Jan-Erik Varhaug; Marek Baranowski; Sylvi Aanderud; Celina Franco; Bo Freyschuss; Gunhild A Isaksen; Thor Ueland; Thord Rosen
Journal:  J Clin Endocrinol Metab       Date:  2007-02-06       Impact factor: 5.958

9.  The changing clinical patterns of primary hyperparathyroidism in Chinese patients: data from 2000 to 2010 in a single clinical center.

Authors:  Lin Zhao; Jian-Min Liu; Xiao-Yan He; Hong-Yan Zhao; Li-Hao Sun; Bei Tao; Min-Jia Zhang; Xi Chen; Wei-Qing Wang; Guang Ning
Journal:  J Clin Endocrinol Metab       Date:  2013-01-30       Impact factor: 5.958

10.  Normocalcemic versus Hypercalcemic Primary Hyperparathyroidism: More Stone than Bone?

Authors:  L M Amaral; D C Queiroz; T F Marques; M Mendes; F Bandeira
Journal:  J Osteoporos       Date:  2012-03-25
View more
  31 in total

Review 1.  Hyperparathyroidism and Bone Health.

Authors:  Francisco Bandeira; Sara Cassibba
Journal:  Curr Rheumatol Rep       Date:  2015-07       Impact factor: 4.592

Review 2.  Management of endocrine disease: Secondary osteoporosis: pathophysiology and management.

Authors:  Faryal Mirza; Ernesto Canalis
Journal:  Eur J Endocrinol       Date:  2015-05-13       Impact factor: 6.664

Review 3.  Primary Hyperparathyroidism.

Authors:  John P Bilezikian
Journal:  J Clin Endocrinol Metab       Date:  2018-11-01       Impact factor: 5.958

4.  Vanishing metatarsal: a rare manifestation of primary hyperparathyroidism.

Authors:  Vikram Singh Shekhawat; Anil Bhansali
Journal:  BMJ Case Rep       Date:  2017-08-01

5.  Kidney stones and crushed bones secondary to hyperparathyroidism.

Authors:  K P Sreelesh; G Nair Sreejith; K Prabhakaran Pranab
Journal:  Proc (Bayl Univ Med Cent)       Date:  2016-01

Review 6.  Skeletal abnormalities in Hypoparathyroidism and in Primary Hyperparathyroidism.

Authors:  Barbara C Silva; John P Bilezikian
Journal:  Rev Endocr Metab Disord       Date:  2020-11-16       Impact factor: 6.514

7.  Overt metabolic bone failure as the initial manifestation of neglected primary hyperparathyroidism: An unusual presentation and review of current practice guidelines.

Authors:  Narendran Pushpasekaran; Gokuldev Vasudevan; Veliyaveettil Muhamed Khaleel; Antony Sebastain; Saubhik Das
Journal:  J Clin Orthop Trauma       Date:  2020-01-22

8.  Progressive rise in the prevalence of asymptomatic primary hyperparathyroidism in India: Data from PHPT registry.

Authors:  Ashutosh Kumar Arya; Poonam Kumari; Sanjay Kumar Bhadada; Kanhaiya Agrawal; Priyanka Singh; Soham Mukherjee; Ashwani Sood; Sudhaker D Rao
Journal:  J Bone Miner Metab       Date:  2020-09-07       Impact factor: 2.626

9.  DXA-Based Bone Strain Index: A New Tool to Evaluate Bone Quality in Primary Hyperparathyroidism.

Authors:  Gaia Tabacco; Anda M Naciu; Carmelo Messina; Gianfranco Sanson; Luca Rinaudo; Roberto Cesareo; Stefania Falcone; Silvia Manfrini; Nicola Napoli; John P Bilezikian; Fabio M Ulivieri; Andrea Palermo
Journal:  J Clin Endocrinol Metab       Date:  2021-07-13       Impact factor: 5.958

10.  Computed Tomography Osteodensitometry for Assessment of Bone Mineral Density of the Canine Head-Preliminary Results.

Authors:  Glynn Woods; Nicolas Israeliantz Gunz; Ian Handel; Tiziana Liuti; Richard J Mellanby; Tobias Schwarz
Journal:  Animals (Basel)       Date:  2021-05-14       Impact factor: 2.752

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.